Do analysts rate ZYXI or NMTC?

NeuroOne Medical Technologies has a consensus price target of $11.67, indicating a potential upside of 558.02%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 NeuroOne Medical Technologies 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Is ZYXI or NMTC more profitable?

NeuroOne Medical Technologies' return on equity of -99.43% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% NeuroOne Medical Technologies -68.35% -99.43% -70.40%

Do analysts prefer TMDIF or ZYXI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is TMDIF or ZYXI more profitable?

Titan Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Titan Medical's return on equity of -82.31% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Titan Medical N/A -82.31% -51.47% Zynex -68.35% -804.30% -36.67%

Do analysts prefer HIND or ZYXI?

Vyome presently has a consensus price target of $15.00, indicating a potential upside of 615.65%. Given Vyome's stronger consensus rating and higher probable upside, research analysts clearly believe Vyome is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vyome 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, HIND or ZYXI?

Zynex has higher revenue and earnings than Vyome. Vyome is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vyome $152.72K 96.32 -$10.26M -$12.27 N/A Zynex $108.20M 0.04 $2.99M -$2.43 N/A

Is HIND or ZYXI more profitable?

Vyome has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Vyome's return on equity of -203.92% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Vyome N/A -203.92% -134.16% Zynex -68.35% -804.30% -36.67%

Do analysts recommend ZYXI or ICU?

SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 133.30%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts clearly believe SeaStar Medical is more favorable than Zynex. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, ZYXI or ICU?

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A SeaStar Medical $1.44M 9.54 -$12.15M -$4.80 N/A

Is ZYXI or ICU more profitable?

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Zynex's return on equity. Company Net Margins Return on Equity Return on Assets Zynex -68.35% -804.30% -36.67% SeaStar Medical -828.62% -146.29% -96.48%

Do analysts rate ZYXI or ZJYL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, ZYXI or ZJYL?

Zynex has higher revenue and earnings than Jin Medical International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zynex $108.20M 0.04 $2.99M -$2.43 N/A Jin Medical International $20.69M 0.65 $1.19M N/A N/A

Zynex (ZYXI) Competitors

$0.12 0.00 (0.00%)

As of 07/31/2026

Compare

ZYXI vs. NMTC, TMDIF, HIND, ICU, and ZJYL

Should you buy Zynex stock or one of its competitors? MarketBeat compares Zynex with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zynex include NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), Vyome (HIND), SeaStar Medical (ICU), and Jin Medical International (ZJYL).

How does Zynex compare to NeuroOne Medical Technologies?

Zynex (NASDAQ:ZYXI) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Zynex has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, NeuroOne Medical Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

29.7% of Zynex shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 49.3% of Zynex shares are owned by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

NeuroOne Medical Technologies' return on equity of -99.43% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
NeuroOne Medical Technologies	-68.35%	-99.43%	-70.40%

NeuroOne Medical Technologies has a consensus price target of $11.67, indicating a potential upside of 558.02%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Zynex has higher revenue and earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
NeuroOne Medical Technologies	$12.10M	1.27	-$3.61M	-$0.85	N/A

In the previous week, NeuroOne Medical Technologies had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for NeuroOne Medical Technologies and 0 mentions for Zynex. NeuroOne Medical Technologies' average media sentiment score of 0.16 beat Zynex's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
NeuroOne Medical Technologies	Neutral

Summary

NeuroOne Medical Technologies beats Zynex on 8 of the 15 factors compared between the two stocks.

How does Zynex compare to Titan Medical?

Titan Medical (NASDAQ:TMDIF) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

In the previous week, Titan Medical's average media sentiment score of 0.00 equaled Zynex'saverage media sentiment score.

Company	Overall Sentiment
Titan Medical	Neutral
Zynex	Neutral

Titan Medical has higher earnings, but lower revenue than Zynex. Zynex is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63M	0.87	$6.95M	$0.05	2.71
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

Titan Medical has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Titan Medical's return on equity of -82.31% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Zynex	-68.35%	-804.30%	-36.67%

Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Zynex has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market.

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by company insiders. Comparatively, 49.3% of Zynex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Titan Medical and Zynex tied by winning 6 of the 12 factors compared between the two stocks.

How does Zynex compare to Vyome?

Vyome (NASDAQ:HIND) and Zynex (NASDAQ:ZYXI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations.

In the previous week, Vyome's average media sentiment score of 0.00 equaled Zynex'saverage media sentiment score.

Company	Overall Sentiment
Vyome	Neutral
Zynex	Neutral

Vyome has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Vyome's return on equity of -203.92% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vyome	N/A	-203.92%	-134.16%
Zynex	-68.35%	-804.30%	-36.67%

Zynex has higher revenue and earnings than Vyome. Vyome is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vyome	$152.72K	96.32	-$10.26M	-$12.27	N/A
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A

Vyome presently has a consensus price target of $15.00, indicating a potential upside of 615.65%. Given Vyome's stronger consensus rating and higher probable upside, research analysts clearly believe Vyome is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vyome	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Vyome has a beta of 1.49, suggesting that its stock price is 49% more volatile than the broader market. Comparatively, Zynex has a beta of 0.99, suggesting that its stock price is 1% less volatile than the broader market.

22.1% of Vyome shares are owned by institutional investors. Comparatively, 29.7% of Zynex shares are owned by institutional investors. 33.0% of Vyome shares are owned by insiders. Comparatively, 49.3% of Zynex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Vyome and Zynex tied by winning 7 of the 14 factors compared between the two stocks.

How does Zynex compare to SeaStar Medical?

Zynex (NASDAQ:ZYXI) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Zynex has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market.

Zynex has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
SeaStar Medical	$1.44M	9.54	-$12.15M	-$4.80	N/A

29.7% of Zynex shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 49.3% of Zynex shares are owned by insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Zynex has a net margin of -68.35% compared to SeaStar Medical's net margin of -828.62%. SeaStar Medical's return on equity of -146.29% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
SeaStar Medical	-828.62%	-146.29%	-96.48%

SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 133.30%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts clearly believe SeaStar Medical is more favorable than Zynex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Zynex's average media sentiment score of 0.00 equaled SeaStar Medical'saverage media sentiment score.

Company	Overall Sentiment
Zynex	Neutral
SeaStar Medical	Neutral

Summary

Zynex beats SeaStar Medical on 9 of the 14 factors compared between the two stocks.

How does Zynex compare to Jin Medical International?

Zynex (NASDAQ:ZYXI) and Jin Medical International (NASDAQ:ZJYL) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Jin Medical International has a net margin of 0.00% compared to Zynex's net margin of -68.35%. Jin Medical International's return on equity of 0.00% beat Zynex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zynex	-68.35%	-804.30%	-36.67%
Jin Medical International	N/A	N/A	N/A

Zynex has higher revenue and earnings than Jin Medical International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zynex	$108.20M	0.04	$2.99M	-$2.43	N/A
Jin Medical International	$20.69M	0.65	$1.19M	N/A	N/A

In the previous week, Jin Medical International had 1 more articles in the media than Zynex. MarketBeat recorded 1 mentions for Jin Medical International and 0 mentions for Zynex. Jin Medical International's average media sentiment score of 0.71 beat Zynex's score of 0.00 indicating that Jin Medical International is being referred to more favorably in the news media.

Company	Overall Sentiment
Zynex	Neutral
Jin Medical International	Positive

29.7% of Zynex shares are held by institutional investors. 49.3% of Zynex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Zynex has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.33, meaning that its stock price is 633% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zynex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Jin Medical International beats Zynex on 7 of the 11 factors compared between the two stocks.

Get Zynex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZYXI vs. The Competition

Export

Metric	Zynex	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.80M	$5.66B	$6.86B	$12.43B
Dividend Yield	N/A	1.78%	2.60%	10.03%
P/E Ratio	-0.05	23.66	280.73	24.99
Price / Sales	0.04	58.68	643.21	112.42
Price / Cash	0.51	32.53	28.64	34.82
Price / Book	0.11	6.51	10.94	6.21
Net Income	$2.99M	$151.15M	$3.48B	$347.49M
7 Day Performance	N/A	3.18%	0.78%	1.28%
1 Month Performance	N/A	-1.01%	-4.20%	-3.62%
1 Year Performance	-92.75%	3.58%	61.51%	18.37%

Zynex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZYXI Zynex	N/A	$0.13 flat	N/A	N/A	$3.80M	$108.20M	N/A	770
NMTC NeuroOne Medical Technologies	3.0935 of 5 stars	$1.67 -5.1%	$11.67 +598.6%	-62.6%	$14.53M	$9.72M	N/A	20	News Coverage
TMDIF Titan Medical	N/A	$0.12 +7.4%	N/A	-58.4%	$14.08M	$17.63M	N/A	50
HIND Vyome	1.8347 of 5 stars	$1.99 -0.5%	$15.00 +653.8%	N/A	$13.97M	$320K	N/A	50	Gap Up
ICU SeaStar Medical	1.7695 of 5 stars	$3.44 -3.6%	$8.00 +132.6%	-51.3%	$13.76M	$1.23M	N/A	2

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ZYXI) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zynex (ZYXI) Competitors

ZYXI vs. NMTC, TMDIF, HIND, ICU, and ZJYL

How does Zynex compare to NeuroOne Medical Technologies?

Summary

How does Zynex compare to Titan Medical?

Summary

How does Zynex compare to Vyome?

Summary

How does Zynex compare to SeaStar Medical?

Summary

How does Zynex compare to Jin Medical International?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Zynex (ZYXI) Competitors

ZYXI vs. NMTC, TMDIF, HIND, ICU, and ZJYL

How does Zynex compare to NeuroOne Medical Technologies?

Which has more risk & volatility, ZYXI or NMTC?

Do insiders & institutionals have more ownership in ZYXI or NMTC?

Is ZYXI or NMTC more profitable?

Do analysts rate ZYXI or NMTC?

Which has stronger earnings and valuation, ZYXI or NMTC?

Does the media prefer ZYXI or NMTC?

Summary

How does Zynex compare to Titan Medical?

Does the media prefer TMDIF or ZYXI?

Which has better earnings & valuation, TMDIF or ZYXI?

Is TMDIF or ZYXI more profitable?

Which has more volatility & risk, TMDIF or ZYXI?

Do insiders & institutionals have more ownership in TMDIF or ZYXI?

Do analysts prefer TMDIF or ZYXI?

Summary

How does Zynex compare to Vyome?

Does the media prefer HIND or ZYXI?

Is HIND or ZYXI more profitable?

Which has preferable valuation & earnings, HIND or ZYXI?

Do analysts prefer HIND or ZYXI?

Which has more volatility & risk, HIND or ZYXI?

Do institutionals & insiders believe in HIND or ZYXI?

Summary

How does Zynex compare to SeaStar Medical?

Which has more volatility and risk, ZYXI or ICU?

Which has higher valuation and earnings, ZYXI or ICU?

Do institutionals and insiders hold more shares of ZYXI or ICU?

Is ZYXI or ICU more profitable?

Do analysts recommend ZYXI or ICU?

Does the media prefer ZYXI or ICU?

Summary

How does Zynex compare to Jin Medical International?

Is ZYXI or ZJYL more profitable?

Which has stronger earnings & valuation, ZYXI or ZJYL?

Does the media refer more to ZYXI or ZJYL?

Do institutionals & insiders hold more shares of ZYXI or ZJYL?

Which has more risk & volatility, ZYXI or ZJYL?

Do analysts rate ZYXI or ZJYL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ZYXI vs. The Competition

Zynex Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools